Titan Stock Future Price Prediction

TTNP -  USA Stock  

USD 2.30  0.06  2.68%

Titan Pharma stock price prediction is an act of determining the future value of Titan Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Titan Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Titan Pharma and does not consider all of the tangible or intangible factors available from Titan Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Titan Pharma, which may create opportunities for some arbitrage if properly timed.
Additionally, take a look at Titan Pharma Basic Forecasting Models to cross-verify your projections.

Search Price Prediction 

 
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Titan Pharma based on different types of headlines from major news networks to social media. The Titan stock price prediction module provides an analysis of price elasticity to changes in media outlook on Titan Pharma over a specific investment horizon. Using Titan Pharma hype-based prediction, you can estimate the value of Titan Pharma from the perspective of Titan Pharma response to recently generated media hype and the effects of current headlines on its competitors.
Titan Pharma Quick Ratio is very stable at the moment as compared to the past year. Titan Pharma reported last year Quick Ratio of 1.84. As of 2nd of August 2021, Net Current Assets as percentage of Total Assets is likely to grow to 67.48, while Cash and Equivalents Turnover is likely to drop 1.46.
This module is based on analyzing investor sentiment around taking a position in Titan Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Titan Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Titan because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Titan Pharma after-hype prediction price

    
  $ 2.24  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Titan Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Titan Pharma in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.553.376.19
Details
Naive
Forecast
LowNext ValueHigh
0.0471322.365.17
Details
1 Analysts
Consensus
LowTarget PriceHigh
7.007.007.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.152.372.59
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Titan Pharma. Your research has to be compared to or analyzed against Titan Pharma's peers to derive any actionable benefits. When done correctly, Titan Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Titan Pharma.

Titan Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Titan Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Titan Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Titan Pharma, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Titan Pharma Estimiated After-Hype Price Volatility

In the context of predicting Titan Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Titan Pharma's historical news coverage. Titan Pharma's after-hype downside and upside margins for the prediction period are 0.11 and 5.06, respectively. We have considered Titan Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.30
2nd of August 2021
2.24
After-hype Price
5.06
Upside
Titan Pharma is relatively risky asset. Analysis and calculation of next after-hype price of Titan Pharma is based on 3 months time horizon.

Titan Pharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Titan Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Titan Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Titan Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.04  2.82  0.00   0.06  5 Events / Month4 Events / MonthIn about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.302.240.00 
9,400  

Titan Pharma Hype Timeline

Titan Pharma is at this time traded for 2.30. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.06. Titan estimated not to react to the next headlinewith price going to stay at about the same level and average media hype impact volatility of over 100%. The immediate return on the next newsis estimated to be very small whereas the daily expected return is at this time at -0.04%. The volatility of relative hype elasticity to Titan Pharma is about 194.48%. The volatility of related hype on Titan Pharma is about 194.48% with expected price after next announcement by competition of 2.36. About 17.0% of the company shares are owned by institutional investors. The book value of Titan Pharma was at this time reported as 1.01. The company recorded a loss per share of 2.83. Titan Pharma had not issued any dividends in recent years. The entity had 1-30 split on the 1st of December 2020. Given the investment horizon of 90 days the next estimatedpress releasewill be in about 5 days.
Additionally, take a look at Titan Pharma Basic Forecasting Models to cross-verify your projections.

Titan Pharma Related Hype Analysis

Having access to credible news sources related to Titan Pharma's direct competition is more important than ever and may enhance your ability to predict Titan Pharma's future price movements. Getting to know how Titan Pharma rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Titan Pharma may potentially react to the hype associated with one of its peers.

Titan Pharma Additional Predictive Modules

Most predictive techniques to examine Titan price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Titan using various technical indicators. When you analyze Titan charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Titan Pharma Predictive Indicators

The successful prediction of Titan Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Titan Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Titan Pharma based on analysis of Titan Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Titan Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Titan Pharma's related companies.
 2015 2016 2020 2021 (projected)
Receivables Turnover0.413.854.434.65
PPandE Turnover1.4515.9818.3826.93

Story Coverage note for Titan Pharma

The number of cover stories for Titan Pharma depends on current market conditions and Titan Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Titan Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Titan Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Contributor Headline

Latest Perspective on Titan Pharma

Titan Pharma Short Properties

Titan Pharma's future price predictability will typically decrease when Titan Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Titan Pharma often depends not only on the future outlook of the potential Titan Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Titan Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out6.89%
Short Percent Of Float6.89%
Float Shares8.49M
Shares Short Prior Month1.05M
Average Daily Volume Last 10 Day60.7k
Average Daily Volume In Three Month138.45k
Date Short Interest28th of May 2021
Additionally, take a look at Titan Pharma Basic Forecasting Models to cross-verify your projections. Note that the Titan Pharma information on this page should be used as a complementary analysis to other Titan Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Titan Stock analysis

When running Titan Pharma price analysis, check to measure Titan Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharma is operating at the current time. Most of Titan Pharma's value examination focuses on studying past and present price action to predict the probability of Titan Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Titan Pharma's price. Additionally, you may evaluate how the addition of Titan Pharma to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
The market value of Titan Pharma is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharma's value that differs from its market value or its book value, called intrinsic value, which is Titan Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharma's market value can be influenced by many factors that don't directly affect Titan Pharma underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Titan Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.